Expression of avian influenza virus hemagglutinin by recombinant fowlpox virus.
A vaccine strain of fowlpox virus (FPV) was genetically engineered to produce avian influenza virus hemagglutinin (HA). This was accomplished by inserting a cDNA copy of the avian influenza virus HA gene, which was regulated by a vaccinia virus promoter, into the FPV thymidine kinase (TK) gene. Two types of recombinant viruses, differing only in the orientation of the HA gene relative to an adjacent foreign gene (lacZ), were created. Following preliminary identification of FPV recombinants based on the generation of beta-galactosidase (lacZ gene product), correct insertion of the HA gene into the genomes of these viruses was verified by hybridization studies. Susceptible chickens vaccinated with these FPV recombinants produced specific hemagglutination-inhibiting antibodies against the HA antigen. In view of this immune response, these viruses may serve as vaccines against avian influenza virus. In this regard, they appeared to be less virulent than the parental virus.
Tripathy
D N
DN
Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Illinois, Urbana 61801.
Schnitzlein
W M
WM
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis*; D002645:Chickens; D005587:Fowlpox virus / Q000235:genetics* / Q000378:metabolism / Q000472:pathogenicity; D015967:Gene Expression Regulation, Viral; D006385:Hemagglutination Inhibition Tests; D006389:Hemagglutinins, Viral / Q000235:genetics* / Q000276:immunology; D009980:Influenza A virus / Q000235:genetics* / Q000276:immunology; D010957:Plasmids; D013047:Specific Pathogen-Free Organisms; D014765:Viral Vaccines / Q000235:genetics / Q000276:immunology; D014774:Virulence
D000914:Antibodies, Viral; D006389:Hemagglutinins, Viral; D014765:Viral Vaccines